Biomimetism to discover and develop new drugs

ENYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.

The company is conducting three Phase 2 with its lead compound Vonafexor (EYP001, a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.

Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications (metabolic diseases, oncology…).